Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

OPT

Opthea (OPT)

Opthea Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OPT
DateTimeSourceHeadlineSymbolCompany
05/28/20246:05AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
02/14/20246:07AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
02/01/20246:04AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
01/11/20246:01AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
12/27/20236:01AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
12/27/20236:00AMGlobeNewswire Inc.Opthea to Receive US$35M Commitment and Additional US$50M FundingNASDAQ:OPTOpthea Ltd
12/19/20236:00AMGlobeNewswire Inc.Opthea Receives A$8.8 million R&D Tax IncentiveNASDAQ:OPTOpthea Ltd
12/01/20235:30AMGlobeNewswire Inc.Opthea to Present at the FLORetina 2023 CongressNASDAQ:OPTOpthea Ltd
11/09/20236:01AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
11/09/20235:30AMGlobeNewswire Inc.Opthea to Present at the Jefferies 2023 London Healthcare ConferenceNASDAQ:OPTOpthea Ltd
10/30/20235:30AMGlobeNewswire Inc.Opthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) ConferenceNASDAQ:OPTOpthea Ltd
10/27/20236:09AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
10/27/20236:06AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
10/27/20235:30AMGlobeNewswire Inc.Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFONASDAQ:OPTOpthea Ltd
10/02/20235:30AMGlobeNewswire Inc.Opthea to Participate at the 2023 Euretina CongressNASDAQ:OPTOpthea Ltd
09/07/20236:04AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
09/07/20235:30AMGlobeNewswire Inc.Opthea to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:OPTOpthea Ltd
08/28/20236:15AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
08/28/20235:30AMGlobeNewswire Inc.Opthea Successfully Completes Institutional Offer and Increases Capital Raising to A$90.0m (US$57.6 million¹)NASDAQ:OPTOpthea Ltd
08/24/20236:16AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
08/01/20236:01AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
07/26/20236:00AMGlobeNewswire Inc.Opthea Announces “Sozinibercept” as the Nonproprietary Drug Name for OPT-302NASDAQ:OPTOpthea Ltd
07/24/20236:01AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
07/24/20236:00AMGlobeNewswire Inc.Opthea to Present at the 2023 Ophthalmology Innovation SummitNASDAQ:OPTOpthea Ltd
07/13/20236:02AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
07/13/20236:00AMGlobeNewswire Inc.Opthea to Feature at the American Society of Retina Specialists 2023 Annual MeetingNASDAQ:OPTOpthea Ltd
07/10/20236:00AMGlobeNewswire Inc.Opthea Announces Departure of Chief Medical Officer and Appointment of Senior Medical AdvisorNASDAQ:OPTOpthea Ltd
06/08/20236:03AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:OPTOpthea Ltd
06/08/20236:00AMGlobeNewswire Inc.Opthea Appoints Anshul Thakral as Non-Executive Director of the BoardNASDAQ:OPTOpthea Ltd
05/25/20238:00AMPR Newswire (Canada)Optiva and lifecell Named as a Nominee in TM Forum's 16th Annual Excellence AwardsNASDAQ:OPTOpthea Ltd
 Showing the most relevant articles for your search:NASDAQ:OPT